Is CRYO-CELL International, Inc. (CCEL) a Stock to Watch After Gaining 7.21% This Week?

Wednesday, April 05, 2023 11:46 AM | InvestorsObserver Analysts

Mentioned in this article

Is CRYO-CELL International, Inc. (CCEL) a Stock to Watch After Gaining 7.21% This Week?

Overall market sentiment has been high on CRYO-CELL International, Inc. (CCEL) stock lately. CCEL receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

CRYO-CELL International, Inc. has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on CCEL!

See Full CCEL Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With CCEL Stock Today?

CRYO-CELL International, Inc. (CCEL) stock has gained 3.48% while the S&P 500 has fallen -0.37% as of 9:49 AM on Wednesday, Apr 5. CCEL has risen $0.11 from the previous closing price of $3.16 on volume of 5,820 shares. Over the past year the S&P 500 is lower by -10.85% while CCEL has fallen -55.81%. CCEL earned $0.47 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 24.11. To screen for more stocks like CRYO-CELL International, Inc. click here.

More About CRYO-CELL International, Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units. Click Here to get the full Stock Report for CRYO-CELL International, Inc. stock.